Long-term persistence of defective HSV-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression

Gene Therapy

Volumn 3, Issue 7, 1996, Pages 615-623

  Starr, P A ^a   Lim, F ^a   Grant, F D ^a   Trask, L ^a   Lang, P ^a   Yu, L ^a   Geller, A I ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Defective viruses; Gene therapy; Genetic vectors; Herpes simplex; Transfection of neurons

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEFECTIVE VIRUS; DNA PACKAGING; DNA REPLICATION; ESCHERICHIA COLI; EXPRESSION VECTOR; HERPES SIMPLEX VIRUS 1; HIPPOCAMPUS; IMMEDIATE EARLY GENE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; VIRUS REACTIVATION;

ANIMALS; BRAIN; CELL LINE; CERCOPITHECUS AETHIOPS; CORPUS STRIATUM; DEFECTIVE VIRUSES; GENE EXPRESSION; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; HIPPOCAMPUS; HUMANS; RATS; SUPERINFECTION; VERO CELLS; VIRUS LATENCY;

ANIMALIA; ESCHERICHIA COLI; HERPES; HUMAN HERPESVIRUS 1;

EID: 0029737010     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ward PL, Roizman B. Herpes simplex genes: the blueprint of a successful pathogen. Trends Genet 1994; 10: 267-274.
2. Dobson AT et al. A latent, nonpathogenic HSV-1-derived vector stably expresses β-galactosidase in mouse neurons. Neuron 1990; 5: 353-360.
3. Fink DJ et al. In vivo expression of beta-galactosidase in hippocampal neurons by HSV-mediated gene transfer. Hum Gene Ther 1992; 3: 11-20.
4. Palella TD et al. Expression of human HPRT mRNA in brains of mice infected with recombinant herpes simplex virus-1 vector. Gene 1989; 80: 137-144.
5. Johnson PA, Yoshida K, Gage FH, Friedmann T. Effects of gene transfer into cultured CNS neurons with a replication-defective herpes simplex virus type 1 vector. Mol Brain Res 1992; 12: 95-102.
6. Spaete RR, Frenkel N. The herpes simplex virus amplicon: a new eucaryotic defective-virus cloning-amplifying vector. Cell 1982; 30. 295-304.
7. Geller AI, Breakefield XO. A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science 1988; 241: 1667-1669.
8. Geller AI, Keyomarsi K, Bryan J, Pardee A. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. Proc Natl Acad Sci USA 1990; 87: 8950-8954.
9. Battleman DS, Geller AI, Chao MV. HSV-1 vector mediated gene transfer of the human nerve growth factor receptor, p75hNGFR, defines high affinity NGF binding. J Neurosci 1993; 13: 941-951.
10. Ho DY, Mocarski ES, Sapolsky RM. Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc Natl Acad Sci USA 1993; 90: 3655-3659.
11. Bergold PJ, Cassaccia-Bonnefil P, Xiu-Liu Z, Federoff H. Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor. Proc Natl Acad Sci USA 1993; 90 6165-6169.
12. Geller AI et al. Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector. Proc Natl Acad Sci USA 1993; 90: 7603-7607.
13. Federoff HJ, Geschwind MD, Geller AI, Kessler JA. Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc Natl Acad Sci USA 1992; 89: 1636-1640.
14. During MJ, Naegele JR, O'Malley KL, Geller AI. Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 1994; 266: 1399-1403.
15. Wood MA et al. Inflammatory effects of gene transfer into the CNS with defective HSV-1 vectors Gene Therapy 1994; 1: 283-291.
16. Kaplitt MG et al. Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector. Proc Natl Acad Sci USA 1994; 91: 8979-8983.
17. Bahr BA et al. Rapid and stable gene expression in hippocampal slice cultures from a defective HSV-1 vector. Mol Brain Res 1994; 26: 277-285.
18. Pakzaban P, Geller AI, Isacson O. Effect of exogenous nerve growth factor on neurotoxicity of and neuronal gene delivery by a herpes simplex amplicon vector in the rat brain. Hum Gene Ther 1994; 5: 987-995.
19. Lim F et al. Generation of high-titer defective HSV-1 vectors using an IE2 deletion mutant and quantitative study of expression in cultured cortical cells. Biotechniques 1996; 20: 460-469.
20. McCarthy AM, McMahan L, Schaffer PA. Herpes simplex type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J Virol 1989; 63: 18-27.
21. Smith IL, Hardwicke MA, Sandri-Goldin RM. Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology 1992; 186: 74-86.
22. Song S et al. Cell type specific expression from the tyrosine hydroxylase promoter may account for the rotational behavior induced by activation of the protein kinase C pathway in substantia nigra pars compacta neurons with a HSV-1 vector. Abs Soc Neurosci 1994; 20: (Abstr. No. 586.10).
23. Paterson T, Everett RD. A prominent serine-rich region in Vmw175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture. J Gen Virol 1990; 71: 1775-1783.
24. Ramakrishran R et al. Competitive quantitative PCR analysis of herpes simplex virus type I DNA and latency-associated transcript RNA in latently infected cells of the rat brain. J Virol 1994; 68: 1864-1873.
25. Fraefel C et al. A helper virus-free packaging system for HSV-1 plasmid vectors. J Virol (submitted).
26. Gussoni E et al. FISH detection of introduced DNA in gene therapy protocols. Nat Biotechnol (submitted).
27. Deluca NA, Schaffer PA. Activation of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res 1987; 15: 4491-4511.
28. Davidson I, Stow ND. Expression of an immediate-early polypeptide and activation of a viral origin of DNA replication in cells containing a fragment of herpes simplex virus DNA. Virology 1985, 141: 77-88.
29. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976; 73: 2424-2428.
30. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-517.
31. Sanes JR, Rubenstein JLR, Nicolas JF. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos- EMBO J 1986; 5: 3133-3142.
32. Spear PG, Roizman B. Herpes simplex viruses. In: Tooze J (ed). DNA Tumor Viruses. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1981, pp 615-746